Locations:

Rheumatology & Immunology

October 17, 2019/Basic & Translational Science

Targeting Tumor Necrosis Factor Pathways in Psoriatic Diseases: The Next Step

Husni lab recently funded by NIH-NIAMS

October 12, 2019/Ophthalmology/Ophthalmology Research

Novel Image Analysis Platform May Detect Early Signs of Retinal Toxicity Secondary to Hydroxychloroquine Use

Research shows ellipsoid zone mapping’s potential

October 1, 2019/Primary Care

The Return of Measles: An Unnecessary Sequel

How to cut through the noise about vaccination

September 23, 2019/Dermatology & Plastic Surgery/Case Studies

Patient Walks Again After Treatment of Severe, Refractory Dermatomyositis

Trials evaluate safety and efficacy of new treatments

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-RHE-1019-littlejohn-leukopeniaLupus-650×450

September 23, 2019/Rheumatology & Immunology/News & Insights

Changes of ANA Titers Over Time: Preclinical to Clinical Lupus

New grant to assess potential significance of serial ANA testing

September 9, 2019/Rheumatology & Immunology/Research

The Search for Prognostic Markers in Patients with Primary Angiitis of the Central Nervous System

New long-term outcomes data offer insights

August 27, 2019/Rheumatology & Immunology/News & Insights

Rheumatic Immune-Related Adverse Events from Checkpoint Inhibitor Therapy: Update

irAEs are a formidable challenge

June 14, 2019/Dermatology & Plastic Surgery

10 Years of Treating TNF-α Inhibitor-Induced Psoriasis

Review is largest study to date of poorly understood entity

May 22, 2019/Rheumatology & Immunology/Arthritis

A Simple Clinical Risk Score for Major NSAID Toxicity

Evidence-based, internally validated method for risk evaluation

May 20, 2019/Pulmonary/Clinical Trial

Trial Results Offer New Hope for Scleroderma Patients

Nintedanib significantly reduces loss of lung function

BackPage 14 of 30Next